Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Stanford University

BioPhotonics
Jan 2007
Stanford University of Palo Alto, Calif., and the Berlin-based Schering AG of the Bayer Group of Leverkusen, Germany, have entered into a joint research program to identify PET tracers for tumor imaging. Schering will have the option to assume exclusive rights to develop and commercialize such tracers, which could enable early detection of pathological changes in the body.

BiophotonicsNews & Featurespathological changesPET tracersStanford University

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.